To: BUCHAREST STOCK EXCHANGE
FINANCIAL SUPERVISORY AUTHORITY
Current report drafted according to the stipulations of ASF Rule no. 5/2018 on issuers of financial instruments and market operations and Law no. 24/2017 on issuers of financial instruments and market operations
Report Date: 12 February 2021
Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")
Unique Registration Code at the National Office of Trade Registry: 8422035
Order number on the Trade Registry: J40/3709/1996
Subscribed and paid-in share capital: 33,217,623 RON
Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category
Significant events to report:
Allocation of free shares issued as a result of the increase of the share capital of the Company, approved by the decision of the Extraordinary General Meeting of Shareholders of the Company dated 15.12.2020
We hereby inform you that, as a result of the issuance by the Financial Supervisory Authority on 12.02.2021 of the Certificate of registration of securities related to the share capital increase of Med Life SA, approved by the decision of the Extraordinary General Meeting of Shareholders of the Company on 15.12.2020 ("Share Capital Increase"), the Central Depository Central communicated to the Company that it will register the effects of the Share Capital Increase in the register of MedLife shareholders and to allocate to the shareholders the newly issued shares, on Monday, 15.02.2021.
All shareholders registered in the Company's shareholders' register as at 04.01.2021, established as the date of registration of the Share Capital Increase, will be allocated free of charge a number of 5 newly issued shares for each share held at the registration date.
President of the Board of Directors